Minkang Guo
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
4-Octyl itaconate-induced Nrf2 nuclear translocation mitigates Caspase-11-dependent noncanonical macrophage pyroptosis and acute lung injury.
Journal: Journal of advanced research
Published: December 11, 2025
IL-27 Aggravates Sepsis-Induced ARDS by Driving Macrophage Ferroptosis Through Activation of NCOA4-Mediated Ferritinophagy.
Journal: Journal of inflammation research
Published: November 18, 2025
Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 21, 2024
IL-27 regulates macrophage ferroptosis by inhibiting the Nrf2/HO1 signaling pathway in sepsis-induced ARDS.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: June 05, 2024
Metabolomic analysis of Agkistrodon haly venom poisoning mouse treatment by Jidesheng snake pill based on GC-MS.
Journal: Frontiers in pharmacology
Published: April 18, 2024
Progranulin promotes regulatory T cells plasticity by mitochondrial metabolism through AMPK/PGC-1α pathway in ARDS.
Journal: Clinical immunology (Orlando, Fla.)
Published: November 01, 2023
Metabolomic analysis of bone-derived exosomes in osteonecrosis of the femoral head based on UPLC-MS/MS.
Journal: Metabolomics : Official journal of the Metabolomic Society
Published: May 21, 2022
Causal roles of daytime sleepiness in cardiometabolic diseases and osteoporosis.
Journal: European review for medical and pharmacological sciences
Published: May 03, 2022
miR-100-5p is involved in non-traumatic osteonecrosis of the femoral head by inhibiting the migration and osteogenic differentiation of BMSCs
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Published: March 31, 2022
Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 21, 2022
Last Updated: 09/26/2026